DrugsControl Media Services
DrugsControl.org

News Detail

IISc scientists develop RS2, thermostable, broadly protective vaccine candidate for current and future SARS-CoV-2 variants (11-01-2024)

Bengaluru, 10 Jan 2024: Since the beginning of the COVID-19 pandemic, Raghavan Varadarajan, Professor at the Molecular Biophysics Unit (MBU), Indian Institute of Science (IISc), and collaborators have been working on developing a heat-tolerant vaccine that can offer protecti......
View Details

Source : Indian Institute of Science
Covid-19 covid vaccine RS2 vaccine Covid crisis Covid India IISc Indian Institute of Science IISc Bangalore Science News India Today Science

Related News